-
Spiroplasma Entry into Drosophila S2 Cells
2026-10-02
This study established Drosophila Schneider 2 cells as an invertebrate model for examining Spiroplasma eriocheiris invasion. Its inhibitor-based experiments identify clathrin-mediated endocytosis and macropinocytosis as major entry routes and show that both actin filaments and microtubules support intracellular infection.
-
SU5416 Workflow for VEGFR2 Angiogenesis Assays
2026-10-01
SU5416 (Semaxanib) enables mechanism-focused studies of VEGFR2 signaling, endothelial proliferation, and VEGF-induced angiogenesis inhibition. This practical workflow also shows how to connect vascular-cell assays with pulmonary hypertension modeling while separating established evidence from hypothesis-generating applications.
-
Pomalidomide (CC-4047) Research Workflows
2026-10-01
Build genotype-aware multiple myeloma assays with Pomalidomide (CC-4047), from DMSO stock preparation and cytokine profiling to viability and HbF readouts. This workflow connects tumor microenvironment modulation with the mutational heterogeneity highlighted in human myeloma cell-line research.
-
CDC42 Polarity and Intestinal Stem Cell Fate
2026-09-30
The reference study identifies CDC42-dependent epithelial polarity as an upstream regulator of the intestinal stem cell to transit-amplifying cell transition. Its genetic and pharmacological experiments place YAP/TAZ–Ereg–mTOR signaling downstream of polarity control and show that restoring cell-fate balance does not necessarily restore epithelial architecture.
-
Drying Strategies for mRNA–Lipid Nanoparticles
2026-09-30
Zhen and colleagues provide a comparative review of freeze-drying and emerging drying technologies for mRNA and other nucleic acid lipid nanoparticles. The analysis shows that solid-state processing could reduce dependence on ultra-low-temperature storage, while emphasizing that cargo structure, formulation composition, drying stresses, reconstitution, and administration route must be evaluated together.
-
Bivalent mRNA–LNP Vaccine Protects Chickens Against H5/H7
2026-09-29
Wei et al. developed a nucleoside-modified mRNA–LNP vaccine encoding H5N1 and H7N9 hemagglutinins and evaluated it in SPF chickens. High-dose vaccination produced strong neutralizing responses, broad protection against lethal homologous and heterologous challenges, reduced viral replication and shedding, and transcriptomic evidence of Th1-associated immune activation.
-
Ridaforolimus at the mTOR–Senescence Interface
2026-09-29
Ridaforolimus (Deforolimus, MK-8669) offers a mechanistically anchored way to study mTOR signaling, cancer-cell growth, angiogenesis, and the unresolved boundary between cytostasis and senolysis. This thought-leadership guide connects its pharmacology with machine-learning-enabled senolytic discovery and outlines a translational validation strategy.
-
METTL3–COL5A2 Axis Suppresses Gastric Cancer Ferroptosis
2026-09-28
A 2026 study links METTL3-driven m6A modification to stabilization of COL5A2 mRNA by IGF2BP3, connecting RNA regulation with FAK/MAPK/ERK signaling and ferroptosis resistance in gastric cancer models. Its cell and xenograft findings identify a testable pathway, while the use of PF-573228 provides pharmacological support for FAK involvement rather than evidence of a treatment-ready strategy.
-
Amplex Red for Redox Assays and Wetland Insights
2026-09-27
Amplex Red converts hydrogen peroxide into a fluorescent readout, making it useful for oxidase activity and extracellular ROS workflows when paired with careful controls. This guide connects assay design to a mangrove carbon study while clarifying what fluorescence can—and cannot—say about iron-driven soil processes.
-
Rotigotine Hydrochloride: From Receptor Signal to Brain Deli
2026-09-26
Explore Rotigotine hydrochloride as a dopamine D2/D3 receptor agonist through a practical lens: how receptor pharmacology, neuronal readouts, and nose-to-brain delivery shape Parkinson’s disease research. A focused analysis of a nanoparticle study helps distinguish drug activity from delivery-system effects.
-
SGK1 Inhibition: From Endothelial Mechanics to Translation
2026-09-26
A translational framework for using EMD638683 to investigate how SGK1 connects salt-responsive signaling with endothelial mechanics, and how to validate that biology without overstating pharmacological or disease-model findings.
-
Atrial Natriuretic Peptide: From Identity to Inference
2026-09-25
Explore how Atrial Natriuretic Peptide can support cardiovascular research when peptide identity, receptor-proximal readouts, and systemic effects are separated in the experimental design. A critical comparison with an aged-rat adiponectin study clarifies what that neuroinflammation evidence can—and cannot—tell researchers about ANP.
-
SB 203580 in Nanoplastic Vascular Signaling Research
2026-09-25
Explore how SB203580 can help test whether p38 signaling contributes to nanoplastic-associated vascular lipid changes—without confusing it with the ERK pathway implicated in a recent developmental study. This article translates the findings into a cautious, branch-specific experimental strategy.
-
Metabolic Sensitization of Ferroptosis and Cuproptosis
2026-09-24
The study combines a copper–tannic acid/liposome system with the metabolic inhibitor STF-31 to make tumor cells more susceptible to ferroptosis and cuproptosis. Its central contribution is a shared metabolic strategy: weakening antioxidant defenses while limiting copper export, with reported additional effects on the tumor immune environment.
-
gamma-Glu-Cys: A Pathway Probe for Peptide Research
2026-09-24
Explore how gamma-Glu-Cys (γ-Glu-Cys) can help distinguish glutathione biosynthesis from broader γ-glutamyl peptide production. This article connects product handling with practical assay decisions and a Bacillus fermentation study, while clarifying what each experimental endpoint can—and cannot—show.